title: Continuous levodopa infusion is better—for now.
authors.affiliation: Oregon Health & Sciences University, Portland, USA.
authors.forename: John G
authors.initials: JG
authors.lastname: Nutt
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001058:Apomorphine / Q000008:administration & dosage*; D002230:Carbidopa / Q000627:therapeutic use*; D005260:Female; D005782:Gels; D006801:Humans; D007422:Intestines / Q000502:physiology*; D007980:Levodopa / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D005782:Gels; D007980:Levodopa; D002230:Carbidopa; D001058:Apomorphine